CHRONIC MIGRAINE
Clinical trials for CHRONIC MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MIGRAINE trials appear
Sign up with your email to follow new studies for CHRONIC MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Zapping the brain to fight debilitating migraines
Disease control CompletedThis study tested whether a painless, non-invasive brain stimulation technique could help people with chronic migraine who also overuse pain medications. Sixty participants received standard detoxification treatment and were randomly assigned to receive either fake stimulation or…
Matched conditions: CHRONIC MIGRAINE
Phase: NA • Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation • Aim: Disease control
Last updated Apr 02, 2026 01:11 UTC
-
Three-Year pill test aims to tame debilitating migraines
Disease control CompletedThis study followed nearly 600 people for three years to check the long-term safety of a daily pill called atogepant, which is designed to prevent migraine attacks. It focused on people who suffer from either chronic (frequent) or episodic (less frequent) migraines. The main goal…
Matched conditions: CHRONIC MIGRAINE
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New migraine shot combo tested in major hospital trial
Symptom relief CompletedThis study tested whether adding platelet-rich plasma (PRP, a substance from a person's own blood) to a standard lidocaine injection for chronic migraine works better than the lidocaine injection alone. Researchers followed 200 adults with chronic migraine to see which treatment …
Matched conditions: CHRONIC MIGRAINE
Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
New migraine drug tested in real patients shows promise
Symptom relief CompletedThis study tested how well lasmiditan works to stop migraine attacks and what side effects people experienced when using it in their daily lives. Researchers followed 100 people with migraines who took lasmiditan tablets during at least four migraine attacks over three months. Th…
Matched conditions: CHRONIC MIGRAINE
Sponsor: University of Florence • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Scientists scan brains to unlock secrets of migraine drug
Knowledge-focused CompletedThis study aimed to understand how a migraine prevention drug, galcanezumab (Emgality), works in the brain. Researchers scanned the brains of 64 people with frequent migraines before and after three months of treatment. They looked for changes in brain activity and structure to s…
Matched conditions: CHRONIC MIGRAINE
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC